Saad F - Search Results

1

Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302).

Rathkopf DE, Smith MR, de Bono JS, Logothetis CJ, Shore ND, de Souza P, Fizazi K, Mulders PF, Mainwaring P, Hainsworth JD, Beer TM, North S, Fradet Y, Van Poppel H, Carles J, Flaig TW, Efstathiou E, Yu EY, Higano CS, Taplin ME, Griffin TW, Todd MB, Yu MK, Park YC, Kheoh T, Small EJ, Scher HI, Molina A, Ryan CJ, Saad F. Rathkopf DE, et al. Among authors: saad f. Eur Urol. 2014 Nov;66(5):815-25. doi: 10.1016/j.eururo.2014.02.056. Epub 2014 Mar 6. Eur Urol. 2014. PMID: 24647231 Free PMC article. Clinical Trial.

2

Role of bisphosphonates in prostate cancer.

Saad F, Schulman CC. Saad F, et al. Eur Urol. 2004 Jan;45(1):26-34. doi: 10.1016/j.eururo.2003.10.003. Eur Urol. 2004. PMID: 14667511 Review.

3

Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer.

Reed SD, Radeva JI, Glendenning GA, Saad F, Schulman KA. Reed SD, et al. Among authors: saad f. J Urol. 2004 Apr;171(4):1537-42. doi: 10.1097/01.ju.0000116777.94426.60. J Urol. 2004. PMID: 15017215 Clinical Trial.

4

uPM3, a new molecular urine test for the detection of prostate cancer.

Fradet Y, Saad F, Aprikian A, Dessureault J, Elhilali M, Trudel C, Mâsse B, Piché L, Chypre C. Fradet Y, et al. Among authors: saad f. Urology. 2004 Aug;64(2):311-5; discussion 315-6. doi: 10.1016/j.urology.2004.03.052. Urology. 2004. PMID: 15302485 Clinical Trial.

5

Natural history and treatment of bone complications in prostate cancer.

Saad F, Clarke N, Colombel M. Saad F, et al. Eur Urol. 2006 Mar;49(3):429-40. doi: 10.1016/j.eururo.2005.12.045. Epub 2006 Jan 6. Eur Urol. 2006. PMID: 16431012 Review.

6

The role of bisphosphonates in the treatment of prostate cancer: recommendations from an expert panel.

Saad F, Higano CS, Sartor O, Colombel M, Murray R, Mason MD, Tubaro A, Schulman C. Saad F, et al. Clin Genitourin Cancer. 2006 Mar;4(4):257-62. doi: 10.3816/CGC.2006.n.004. Clin Genitourin Cancer. 2006. PMID: 16729908 Review.

7

Sunitinib relieves renal cell carcinoma spinal cord compression.

Trinh QD, Cardinal E, Gallina A, Perrotte P, Saad F, Karakiewicz PI. Trinh QD, et al. Among authors: saad f. Eur Urol. 2007 Jun;51(6):1741-3. doi: 10.1016/j.eururo.2006.10.050. Epub 2006 Nov 3. Eur Urol. 2007. PMID: 17126991

8

Predictors of skeletal complications in men with hormone-refractory metastatic prostate cancer.

Smith MR, Cook RJ, Coleman R, Brown J, Lipton A, Major P, Hei YJ, Saad F. Smith MR, et al. Among authors: saad f. Urology. 2007 Aug;70(2):315-9. doi: 10.1016/j.urology.2007.03.071. Urology. 2007. PMID: 17826496 Free PMC article. Clinical Trial.

9

A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer.

Carducci MA, Saad F, Abrahamsson PA, Dearnaley DP, Schulman CC, North SA, Sleep DJ, Isaacson JD, Nelson JB; Atrasentan Phase III Study Group Institutions. Carducci MA, et al. Among authors: saad f. Cancer. 2007 Nov 1;110(9):1959-66. doi: 10.1002/cncr.22996. Cancer. 2007. PMID: 17886253 Free article. Clinical Trial.

10

Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.

Jeldres C, Suardi N, Walz J, Saad F, Hutterer GC, Bhojani N, Shariat SF, Perrotte P, Graefen M, Montorsi F, Karakiewicz PI. Jeldres C, et al. Among authors: saad f. Eur Urol. 2008 Jul;54(1):107-16. doi: 10.1016/j.eururo.2007.10.038. Epub 2007 Oct 30. Eur Urol. 2008. PMID: 17996358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,351 results

Search Page